4.7 Review

High burden of antimicrobial resistance in Asia

期刊

出版社

ELSEVIER
DOI: 10.1016/j.ijantimicag.2011.01.009

关键词

Antimicrobial resistance; Multidrug-resistant; Extensively drug-resistant; Extended-spectrum beta-lactamase; Asia

向作者/读者索取更多资源

Antimicrobial resistance is associated with high mortality rates and high medical costs. Marked variations in the resistance profiles of bacterial and fungal pathogens as well as the quality of public hygiene have had a considerable impact on the effectiveness of antimicrobial agents in Asian countries. In Asia, one of the epicentres of antimicrobial drug resistance, there is an alarming number of antibiotic-resistant species, including penicillin- and erythromycin-resistant Streptococcus pneumoniae, ampicillin-resistant Haemophilus influenzae, multidrug-resistant (MDR) Acinetobacter baumannii, extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae (particularly mediated by CTX-M-9, CTX-M-14 and CTX-M-15), New Delhi metallo-beta-lactamase 1 (NDM-1)-producing Enterobacteriaceae, MDR Salmonella enterica serotypes Choleraesuis and Typhi, carbapenem-resistant A. baumannii (OXA-58 and OXA-23 carbapenemases) and azole-resistant Candida glabrata. A few clones of MDR A. baumannii and hospital-acquired meticillin-resistant Staphylococcus aureus (MRSA) have been widely disseminated in hospital settings in Asia, and K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains have been widely distributed in China. In addition, the emergence of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) has illustrated the need for regular monitoring of resistance profiles of clinical isolates as well as the deliberative use of fluoroquinolones. Continuous surveillance of resistance data from clinical isolates as well as implementation of strict infection control policies in healthcare settings are required to mitigate the progression of antimicrobial resistance. (c) 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China

Ran Jing, Wen-Hang Yang, Meng Xiao, Ying Li, Gui-Ling Zou, Cheng-Ying Wang, Xiu-Wen Li, Ying-Chun Xu, Po-Ren Hsueh

Summary: This study provides valuable insights on the species distribution and susceptibility of Aspergillus strains isolated from otomycosis patients in China. The findings highlight the prevalence of A. welwitschiae and the existence of azole-resistance, which can guide clinical medication for otomycosis.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2022)

Article Immunology

Potentially conjugative plasmids harboring Tn6636, a multidrug-resistant and composite mobile element, in Staphylococcus aureus

Tsai-Wen Wan, Yu-Jung Liu, Yu-Ting Wang, Yu-Tzu Lin, Jia-Chuan Hsu, Jui-Chang Tsai, Hao-Chieh Chiu, Po -Ren Hsueh, Wei-Chun Hung, Lee-Jene Teng

Summary: This study provides detailed genetic characterization of Tn6636, a multidrug-resistant mobile element, in clinical isolates of Staphylococcus aureus. The prevalence of Tn6636 in methicillin-susceptible S. aureus (MSSA) is higher than that in methicillin-resistant S. aureus (MRSA). The presence of this mobile element with various sequence types suggests its broad dissemination and the potential for continued spread of resistant plasmids.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2022)

Article Immunology

Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019

Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, Po-Liang Lu, Shu-Hsing Cheng, Wen-Chien Ko, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Wen-Sen Lee, Zhi-Yuan Shi, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Chao-Nan Lin, Yu-Hui Chen, Wang-Huei Sheng, Chun-Ming Lee, Hung-Jen Tang, Chun-Yu Lin, Yen-Hsu Chen, Po-Ren Hsueh

Summary: The study suggests that empirical treatment with ceftriaxone monotherapy for pneumococcal meningitis should be carefully monitored due to its high non-susceptibility rate. However, the high susceptibility rates of most isolates to other antibiotics such as penicillin, carbapenems, respiratory quinolones, vancomycin, and linezolid indicate their potential in treating pneumococcal diseases in Taiwan.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2022)

Article Microbiology

Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015-2019

Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh

Summary: This study investigated the resistance patterns and mechanisms of Pseudomonas aeruginosa in the Asia-Pacific region from 2015 to 2019. The results showed significant variations in resistance patterns and associated genes among different countries in the region.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Letter Infectious Diseases

FilmArray Meningitis/Encephalitis (M/E) false-negative for cryptococcal meningitis

Pin-Han Wu, Chih-Hao Chen, Chia-Huei Chou, Mao-Wang Ho, Yu-Hsuan Liu, Hsiu-Hsien Lin, Kuan-Fei Chen, Po-Ren Hsueh

JOURNAL OF INFECTION (2022)

Letter Infectious Diseases

BioFire FilmArray respiratory panel RP2.1 for SARS-CoV-2 detection: The pitfalls

Yu-Chang Chang, Chiung-Tzu Hsiao, Wan-Li Chen, Yang-Di Su, Po-Ren Hsueh

JOURNAL OF INFECTION (2022)

Article Microbiology

Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units

Jung-Yien Chien, Chong-Jen Yu, Po-Ren Hsueh

Summary: The performance of metagenomic next-generation sequencing (mNGS) was evaluated and compared with that of conventional culture testing in patients with sepsis. mNGS had higher detection rates than blood culture and BALF culture, especially for bacteria, viruses, and multipathogen infections. RNA-based mNGS increased the detection rate of several bacteria, fungi, and viruses. mNGS offers a sensitive diagnostic method for patients with sepsis, but clinical correlation is advised to interpret the data due to the lack of unified diagnostic criteria.

MICROBIOLOGY SPECTRUM (2022)

Letter Infectious Diseases

Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan

Jia-Arng Lee, Shin-Hei Du, Tai-fen Lee, Yu-Shan Huang, Chun-Hsing Liao, Yu-Tsung Huang, Po-Ren Hsueh

JOURNAL OF INFECTION (2023)

Letter Infectious Diseases

Direct prediction of ceftazidime-resistant Stenotrophomonas maltophilia from routine MALDI-TOF mass spectra using machine learning

Jiaxin Yu, Hsiu-Hsien Lin, Kun-Hao Tseng, Ni Tien, Po-Ren Hsueh, Der-Yang Cho

JOURNAL OF INFECTION (2023)

Review Virology

Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomes

Chih-Cheng Lai, Chi-Kuei Hsu, Shun-Chung Hsueh, Muh-Yong Yen, Wen-Chien Ko, Po-Ren Hsueh

Summary: Following the emergence of multisystem inflammatory syndrome in children (MIS-C), a similar clinical scenario called multisystem inflammatory syndrome in adults (MIS-A) has been observed. Although the prevalence of MIS-A is low and likely underdiagnosed, it can be associated with high mortality. MIS-A is a multisystem disease that affects the cardiovascular, respiratory, gastrointestinal, dermatologic, hematologic, and neurologic systems. The diagnosis of MIS-A requires clinical manifestations, laboratory evidence of inflammation, and SARS-CoV-2 infection. The appropriate treatment for MIS-A is still uncertain, but anti-inflammatory agents like intravenous immunoglobulin and corticosteroids are commonly used. Further research is needed to determine the true prevalence, pathogenesis, and effective treatment for MIS-A.

JOURNAL OF MEDICAL VIROLOGY (2023)

Review Virology

Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment

Chih-Cheng Lai, Po-Ren Hsueh

Summary: Nirmatrelvir/ritonavir (NMV-r) is an effective antiviral agent for treating nonhospitalized COVID-19 patients. However, there have been rare cases of virologic and symptomatic rebound after NMV-r treatment, which is a cause for concern. This review provides comprehensive information on the frequency, mechanism, outcomes, and management of COVID-19 rebound after NMV-r. The incidence of rebound was less than 2% and most cases had mild symptoms, with favorable clinical outcomes.

JOURNAL OF MEDICAL VIROLOGY (2023)

Letter Infectious Diseases

Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan

Pin-Han Wu, Chih-Hao Chen, Wen-Hsin Hsih, Chia-Huei Chou, Chih-Yu Chi, Mao-Wang Ho, Yu-Tzu Lin, Hsiu-Hsien Lin, Kun-Hao Tseng, Po-Ren Hsueh

JOURNAL OF INFECTION (2023)

Article Immunology

Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan

I-Ru Chen, Guei-Jane Wang, Po-Ren Hsueh, Chia-Hui Chou, Long-Bin Jeng, Hui-Ju Lin, Huang-Jiun Liao, Ping-Chin Lai, Jan-Gowth Chang, Chiu-Ching Huang

Summary: This study evaluated the immune responses and safety of COVID-19 vaccination in patients with atypical hemolytic uremic syndrome (aHUS) in Taiwan. The results showed that the vaccines effectively protected aHUS patients from severe COVID-19 complications without significant safety concerns. Transplant aHUS patients had lower immune response titers, indicating a need for additional vaccine doses.

VACCINE (2023)

Article Microbiology

Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant Enterobacterales Isolates Associated with Bloodstream Infection

Yu-Tsung Huang, Yao-Wen Kuo, Nan-Yao Lee, Ni Tien, Chun-Hsing Liao, Lee-Jene Teng, Wen-Chien Ko, Po-Ren Hsueh

Summary: Detection of carbapenemase-producing Enterobacterales is important for therapeutic decisions and infection control. The Xpert CARBA-R and NG-Test CARBA 5 assays showed high sensitivity and specificity in detecting carbapenemases in carbapenem-resistant Enterobacterales isolates.

MICROBIOLOGY SPECTRUM (2022)

Review Infectious Diseases

Lenacapavir: A novel injectable HIV-1 capsid inhibitor

Allison M. Hitchcock, Wesley D. Kufel, Keri A. Mastro Dwyer, Eric F. Sidman

Summary: Lenacapavir is a novel HIV-1 treatment option for patients with multidrug-resistant (MDR) HIV-1 infection. It has a favorable pharmacokinetic profile and has shown good tolerability and efficacy in clinical trials.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)

Article Infectious Diseases

Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort

Roberta Gagliardini, Alessandro Tavelli, Stefano Rusconi, Sergio Lo Caputo, Vincenzo Spagnuolo, Maria Mercedes Santoro, Andrea Costantini, Alessandra Vergori, Franco Maggiolo, Andrea Giacomelli, Giulia Burastero, Giordano Madeddu, Eugenia Quiros Roldan, Antonella d'Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri

Summary: This study evaluated multiple treatment failures to modern antiretroviral therapy in HIV-infected individuals and found that approximately 4% of them were difficult to treat. The difficult to treat group, compared to the non-difficult to treat group, was characterized by older age, higher prevalence of AIDS, lower CD4+ cell count, and higher risk of treatment failure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)